Zymeworks Announces Leadership Appointments and Transitions on January 12, 2026
Zymeworks announced leadership changes effective January 12, 2026, to align with its corporate strategy from November 2025.135
Brian Cherry appointed to the Board of Directors, bringing over 25 years of investment experience in healthcare and other sectors.14
Mark Hollywood promoted to Executive Vice President and Chief Operating Officer with expanded responsibilities.1
Dr. Sabeen Mekan promoted to Senior Vice President and Chief Medical Officer effective February 1, 2026; current CMO Dr. Jeff Smith retires January 31, 2026, and will advise during transition.1
Five new Vice Presidents appointed:
Laura O’Connor (Chief HR Officer), Bijal Desai (Finance), Lindsey Foulkes (Corporate Development), Charles Chen (Translational Sciences), Shrinal Inamdar (Investor Relations), Diana Papove (Corporate Communications), Victoria Spencer (Treasury and Tax), Lingxing Zheng (Regulatory Affairs).1
Departures:
CFO search initiated after Q1 2026 exits; Leone Patterson (CFO) and Daniel Dex (General Counsel) departing in Q1 2026; Kenneth Galbraith acting CFO.134
Sources:
1. https://www.stocktitan.net/news/ZYME/zymeworks-announces-leadership-appointments-and-transitions-to-align-uthe34f8rduv.html
3. https://www.nasdaq.com/press-release/zymeworks-announces-leadership-appointments-and-transitions-align-evolution-0
4. https://www.streetinsider.com/Corporate+News/Zymeworks+appoints+Brian+Cherry+to+board,+promotes+executives/25833469.html